Diabetic Medicine logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 24, Number 5, May 2007

< previous issue | all issues | next issue >

International Diabetes Federation: a consensus on Type 2 diabetes prevention
pp. 451-463(13)
Authors: Alberti, K. G. M. M.; Zimmet, P.; Shaw, J.

Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a ‘real world’ routine healthcare setting: model based on the KORA Survey 2000
pp. 473-480(8)
Authors: Icks, A.; Rathmann, W.; Haastert, B.; Gandjour, A.; Holle, R.; John, J.; Giani, G.

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia
pp. 481-485(5)
Authors: Spelman, L. M.; Walsh, P. I.; Sharifi, N.; Collins, P.; Thakore, J. H.

Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis
pp. 486-493(8)
Authors: Jennings, D. L.; Kalus, J. S.; Coleman, C. I.; Manierski, C.; Yee, J.

Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin
pp. 494-497(4)
Authors: Warren, R. E.; Strachan, M. W. J.; Wild, S.; McKnight, J. A.

Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus
pp. 498-504(7)
Authors: van Greevenbroek, M. M. J.; Vermeulen, V. M. M-J.; Feskens, E. J. M.; Evelo, C. T.; Kruijshoop, M.; Hoebee, B.; van der Kallen, C. J. H.; de Bruin, T. W. A.

Achievement of metabolic targets for diabetes by English primary care practices under a new system of incentives
pp. 505-511(7)
Authors: Gulliford, M. C.; Ashworth, M.; Robotham, D.; Mohiddin, A.

Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission
pp. 512-520(9)
Authors: Schloot, N. C.; Hanifi-Moghaddam, P.; Aabenhus-Andersen, N.; Alizadeh, B. Z.; Saha, M. T.; Knip, M.; Devendra, D.; Wilkin, T.; Bonifacio, E.; Roep, B. O.; Kolb, H.

GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination
pp. 521-526(6)
Authors: Bekris, L. M.; Jensen, R. A.; Lagerquist, E.; Hall, T. R.; Agardh, C.-D.; Cilio, C. M.; Lethagen, Å. L.; Lernmark, Å.; Robertson, J. A.; Hampe, C. S.

Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations
pp. 527-532(6)
Authors: Wentholt, I. M. E.; Maran, A.; Masurel, N.; Heine, R. J.; Hoekstra, J. B. L.; DeVries, J. H.

Assessment of an empowerment education programme. A randomized study in teenagers with diabetes
pp. 550-556(7)
Authors: Viklund, G.; Örtqvist, E.; Wikblad, K.

Patient and professional accuracy of recalled treatment decisions in out-patient consultations
pp. 557-560(4)
Authors: Skinner, T. C.; Barnard, K.; Cradock, S.; Parkin, T.

Perinatal risk factors for childhood Type 1 diabetes in Western Australia—a population-based study (1980–2002)
pp. 564-570(7)
Authors: Haynes, A.; Bower, C.; Bulsara, M. K.; Finn, J.; Jones, T. W.; Davis, E. A.

Time to move from serum creatinine to eGFR
pp. 571-571(1)
Authors: Bilo, H. J. G.; Logtenberg, S. J. J.; de Grauw, W. J. C.; Kleefstra, N.; Wolffenbuttel, B. H. R.

Is the concept of ‘cardiometabolic risk’ more useful than ‘metabolic syndrome’?
pp. 571-571(1)
Authors: Koshiyama, H.; Taniguchi, A.; Inagaki, N.; Seino, Y.

Authors’ response
pp. 572-573(2)
Authors: New, J. P.; O'Donoghue, D. J.; Middleton, R. J.; Rudenski, A.; Dasgupta, I.; Marshall, S. M.

Diary dates
pp. 574-574(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page